A Trial of PDL192 in Subjects With Advanced Solid Tumors
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | July 2008 |
| End Date: | December 2011 |
A Phase 1, Multicenter, Open-Label, Dose Escalation Trial of PDL192 in Subjects With Advanced Solid Tumors
This is a phase 1, multicenter, open-label, dose escalation trial of PDL192 in subjects with
advanced solid tumors.
The primary study objective is to determine the maximum tolerated dose of PDL192 in subjects
with advanced solid tumors.
We found this trial at
2
sites
Click here to add this to my saved trials
Click here to add this to my saved trials